Back

Outcomes in patients with prior myocardial infarction in PARADIGM-HF

28 August 2016 (09:15 - 09:24)
Organised by:
Congress Presentation Part of: Heart failure prognosis Prognosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Ulrik Madvig Mogensen

Zealand University Hospital, Roskilde (Denmark)

9 More presentations in this session

Presentation thumbnail
Prognostic role of atrial fibrillation in predominantly elderly patients insight from different EF-HF phenotypes.
Doctor A. Di Lenarda (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
The impact of severe mitral insufficiency on outcome and treatment qualification in systolic heart failure patients - insights from the COMMIT-HF registry
Doctor L. Pyka (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Prognostic nutrition index and the risk of mortality in patients with acute heart failure
Doctor Y. Cheng (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Fibrosis as assessed by magnetic resonance predicts death and arrhythmias in patients with implanted cardioverter defibrillators
Doctor G. Casolo (Lido Di Camaiore, IT)
Abstract Slides Video
Presentation thumbnail
Outcomes in patients with and without atrial fibrillation in PARADIGM-HF and effect of sacubitril/valsartan according to atrial fibrillation status
Doctor U. Mogensen (Roskilde, DK)
Abstract

Access the full session

Session thumbnail
Heart failure prognosis

The Event

Event poster

ESC Congress 2016

28 August 2016 09:15 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure post-acute myocardial infarction
12 January 2021
thumbnail
Congress Presentation
Can we expect results in addition to the paradigm and provide trial with use of Sacubitril/Valsartan in a real life cohort?
29 June 2021
thumbnail
Congress Presentation
Association of HF onset with long-term survival in patients with or without prior myocardial infarction
21 May 2023
thumbnail
Congress Presentation
Differences in risk profiles and clinical outcomes according to age in patients with high-risk myocardial infarction: insights from the PARADISE-MI trial
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources